Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 920-031-1 | CAS number: -
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
Ames (according to OECD 471 and EC B.13/14):
All bacterial strains showed negative responses over the entire dose range, i.e. no significant dose-related increase in the number of revertants in two independently repeated experiments with and without metabolic activation. Based on the results of this study it is concluded that Biomass residue (liquid) obtained after B2 production is not mutagenic in the Salmonella typhimurium reverse mutation assay and in the Escherichia coli reverse mutation assay.
Chromosome aberration test (according to OECD 473 and EC B.10):
No effects of Biomass residue (liquid) obtained after B2 production on the number of polyploid cells and cells with endoreduplicated chromosomes were observed both in the absence and presence of S9-mix. Therefore it can be concluded that Biomass residue (liquid) obtained after B2 production does not disturb mitotic processes and cell cycle progression and does not induce numerical chromosome aberrations.
Mouse lymphoma test (according to OECD 476 and EC B.17): In the absence of S9-mix, Biomass residue (liquid) obtained after B2 production did not induce a significant increase in the mutation frequency in the first experiment. This result was confirmed in an independent repeat experiment with modifications in the duration of treatment time.
In the presence of S9-mix, Biomass residue (liquid) obtained after B2 production did not induce a significant increase in the mutation frequency in the first experiment. This result was confirmed in an independent repeat experiment with modifications in the concentration of the S9 for metabolic activation.
Based on the above mentioned results it is concluded that Biomass residue (liquid) obtained after B2 production is not mutagenic in the mouse lymphoma L5178Y test system under the experimental conditions tested.
Short description of key information:
Reliable in vitro studies according to OECD and GLP are available to cover the genetic toxicity endpoint: Ames test, chromosome aberration assay and mouse lymphoma test.
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
Based on the results of the genotoxicity studies, the substance does not need to be classified according to the CLP Regulation (EC) 1272/2008 and Council Directive 67/548/EEC (DSD).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
